Addition of Lithium to Radioactive Iodine Treatment With Improved Response in a Woman With Progressive Papillary Thyroid Carcinoma
ABSTRACT: Objective: Differentiated thyroid carcinoma (DTC) treatment includes surgery and therapy with radioactive iodine (RAI) (131I) of thyroid remnants and metastases. The objective of this report is to describe an improved response in a woman with progressive papillary thyroid carcinoma, and ad...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-01-01
|
Series: | AACE Clinical Case Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2376060520302868 |
id |
doaj-f1d9cb9b483e47e188de9bb75ebfdd79 |
---|---|
record_format |
Article |
spelling |
doaj-f1d9cb9b483e47e188de9bb75ebfdd792021-04-30T07:24:14ZengElsevierAACE Clinical Case Reports2376-06052016-01-0122e96e99Addition of Lithium to Radioactive Iodine Treatment With Improved Response in a Woman With Progressive Papillary Thyroid CarcinomaMaríadel Mar Navarro-Pelayo Láinez, MD0Maria Angustias Muros de Fuentes, MD, PhD1Martín López de la Torre Casares, MD, PhD2José Manuel Llamas Elvira, MD, PhD3Department of Nuclear Medicine, and; Address correspondence to Dr. María del Mar Navarro-Pelayo Láinez, Department of Nuclear Medicine, Virgen de las Nieves University Hospital, Avenue Fuerzas Armadas, 2, 18014, Granada, Spain.Department of Nuclear Medicine, andDepartment of Endocrinology, Virgen de las Nieves University Hospital, Granada, Spain.Department of Nuclear Medicine, andABSTRACT: Objective: Differentiated thyroid carcinoma (DTC) treatment includes surgery and therapy with radioactive iodine (RAI) (131I) of thyroid remnants and metastases. The objective of this report is to describe an improved response in a woman with progressive papillary thyroid carcinoma, and adjuvant lithium carbonate therapy in order to enhance 131I efficacy.Methods: A young woman underwent total thyroidectomy with bilateral cervical lymph node dissection for a multicentric papillary carcinoma. Despite 8 therapeutic doses of 131I, the patient showed a negative 131I scan and increasing thyroglobulin values. After preparation with oral administration of 600 mg of lithium and a 15-day regimen of 300 mg (3 times/day), which was adjusted according to the patient's daily recorded serum lithium level, a dose of 150 mCi of 131I was administered on day 15.Results: After this procedure, the patient showed for 5 continuous years the lowest thyroglobulin levels observed during her follow-up, and she remains clinically and radiologically stable.Conclusion: In progressive, high-risk DTC with 131I-resistant metastatic disease, the combination of radioiodine with lithium in an adequately controlled protocol might be of benefit. Prospective studies comparing RAI therapy alone to RAI therapy plus lithium in similar groups of patients with DTC are needed to demonstrate that lithium with RAI therapy is superior to RAI therapy alone.Abbreviations: DTC = differentiated thyroid carcinoma RAI = radioactive iodine Tg = thyroglobulin TSH = thyroid-stimulating hormonehttp://www.sciencedirect.com/science/article/pii/S2376060520302868 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Maríadel Mar Navarro-Pelayo Láinez, MD Maria Angustias Muros de Fuentes, MD, PhD Martín López de la Torre Casares, MD, PhD José Manuel Llamas Elvira, MD, PhD |
spellingShingle |
Maríadel Mar Navarro-Pelayo Láinez, MD Maria Angustias Muros de Fuentes, MD, PhD Martín López de la Torre Casares, MD, PhD José Manuel Llamas Elvira, MD, PhD Addition of Lithium to Radioactive Iodine Treatment With Improved Response in a Woman With Progressive Papillary Thyroid Carcinoma AACE Clinical Case Reports |
author_facet |
Maríadel Mar Navarro-Pelayo Láinez, MD Maria Angustias Muros de Fuentes, MD, PhD Martín López de la Torre Casares, MD, PhD José Manuel Llamas Elvira, MD, PhD |
author_sort |
Maríadel Mar Navarro-Pelayo Láinez, MD |
title |
Addition of Lithium to Radioactive Iodine Treatment With Improved Response in a Woman With Progressive Papillary Thyroid Carcinoma |
title_short |
Addition of Lithium to Radioactive Iodine Treatment With Improved Response in a Woman With Progressive Papillary Thyroid Carcinoma |
title_full |
Addition of Lithium to Radioactive Iodine Treatment With Improved Response in a Woman With Progressive Papillary Thyroid Carcinoma |
title_fullStr |
Addition of Lithium to Radioactive Iodine Treatment With Improved Response in a Woman With Progressive Papillary Thyroid Carcinoma |
title_full_unstemmed |
Addition of Lithium to Radioactive Iodine Treatment With Improved Response in a Woman With Progressive Papillary Thyroid Carcinoma |
title_sort |
addition of lithium to radioactive iodine treatment with improved response in a woman with progressive papillary thyroid carcinoma |
publisher |
Elsevier |
series |
AACE Clinical Case Reports |
issn |
2376-0605 |
publishDate |
2016-01-01 |
description |
ABSTRACT: Objective: Differentiated thyroid carcinoma (DTC) treatment includes surgery and therapy with radioactive iodine (RAI) (131I) of thyroid remnants and metastases. The objective of this report is to describe an improved response in a woman with progressive papillary thyroid carcinoma, and adjuvant lithium carbonate therapy in order to enhance 131I efficacy.Methods: A young woman underwent total thyroidectomy with bilateral cervical lymph node dissection for a multicentric papillary carcinoma. Despite 8 therapeutic doses of 131I, the patient showed a negative 131I scan and increasing thyroglobulin values. After preparation with oral administration of 600 mg of lithium and a 15-day regimen of 300 mg (3 times/day), which was adjusted according to the patient's daily recorded serum lithium level, a dose of 150 mCi of 131I was administered on day 15.Results: After this procedure, the patient showed for 5 continuous years the lowest thyroglobulin levels observed during her follow-up, and she remains clinically and radiologically stable.Conclusion: In progressive, high-risk DTC with 131I-resistant metastatic disease, the combination of radioiodine with lithium in an adequately controlled protocol might be of benefit. Prospective studies comparing RAI therapy alone to RAI therapy plus lithium in similar groups of patients with DTC are needed to demonstrate that lithium with RAI therapy is superior to RAI therapy alone.Abbreviations: DTC = differentiated thyroid carcinoma RAI = radioactive iodine Tg = thyroglobulin TSH = thyroid-stimulating hormone |
url |
http://www.sciencedirect.com/science/article/pii/S2376060520302868 |
work_keys_str_mv |
AT mariadelmarnavarropelayolainezmd additionoflithiumtoradioactiveiodinetreatmentwithimprovedresponseinawomanwithprogressivepapillarythyroidcarcinoma AT mariaangustiasmurosdefuentesmdphd additionoflithiumtoradioactiveiodinetreatmentwithimprovedresponseinawomanwithprogressivepapillarythyroidcarcinoma AT martinlopezdelatorrecasaresmdphd additionoflithiumtoradioactiveiodinetreatmentwithimprovedresponseinawomanwithprogressivepapillarythyroidcarcinoma AT josemanuelllamaselviramdphd additionoflithiumtoradioactiveiodinetreatmentwithimprovedresponseinawomanwithprogressivepapillarythyroidcarcinoma |
_version_ |
1721498545575428096 |